Study rejects link between digoxin, mortality risk in A-fib patients

04/18/2013 | MedPage Today (free registration)

Taking digoxin does not increase the risk of mortality, hospital admissions or incident nonfatal arrhythmia in patients with atrial fibrillation, according to a study published online in the European Heart Journal. Researchers analyzed data from the AFFIRM study and found no significant difference in rate of all-cause death between digoxin users and nonusers.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ